Streptococcal Infections
Showing 1 - 25 of 8,810
Adjunctive Clindamycin Versus Linezolid for ß-lactam Treated
Active, not recruiting
- Streptococcal Sepsis
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center (primary center co
Nov 8, 2023
Invasive Group A Streptococcal Infection
Recruiting
- Sepsis Due to Streptococcus, Group A
- +8 more
-
Créteil, FranceACTIV
Mar 16, 2023
Invasive Group B Streptococcus Disease Burden and Its
Recruiting
- Invasive Infection
- +3 more
- No Intervention in This study
-
Serdang, Selangor, MalaysiaFaculty of Medicine and Health Sciences
Feb 11, 2023
Streptococcus Pyogenes Carriage Acquisition and Transmission
Completed
- Group A Streptococcal Infection
- +2 more
-
Fajara, GambiaMRC Unit The Gambia at LSHTM
Nov 21, 2022
Group B Streptococcal Infections Trial in Ghent (GBS-NN/NN2, Placebo)
Recruiting
- Group B Streptococcal Infections
- GBS-NN/NN2
- Placebo
-
Ghent, BelgiumUniversity Hospital Ghent - Centrum voor Vaccinologie (CEVAC) de
Mar 21, 2023
Group B Streptococcal Infection Trial in Kawempe (GBS6)
Recruiting
- Group B Streptococcal Infection
-
Kawempe, UgandaMakerere University, John Hopkins University
Apr 14, 2023
Pneumococcal Infections, Streptococcal Infections, Bacterial Infections Trial in Anyang (13-Valent Pneumococcal Polysaccharide
Active, not recruiting
- Pneumococcal Infections
- +2 more
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(CRM197,TT)
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
-
Anyang, Henan, ChinaNeihuang Center for Disease Control and Prevention
Oct 28, 2022
Strepic® Device for Diagnosis of Group A Streptococcal
Completed
- Group A Streptococcal Infection
- Strepic® Device
-
Sylmar, CaliforniaOlive View-UCLA Medical Center
Apr 18, 2022
Group A Streptococcal Infection Trial in Madison (LolliTest, Lollipop Swab)
Not yet recruiting
- Group A Streptococcal Infection
- LolliTest
- Lollipop Swab
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Jul 18, 2022
Group A Streptococcal Infection Trial in Edmonton (p*17-K4S2 (25 µg/mL), J8-K4S2 (100 µg/mL), p*17-K4S2 (50 µg/mL))
Not yet recruiting
- Group A Streptococcal Infection
- p*17-K4S2 (25 µg/mL)
- +4 more
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
Jul 26, 2022
Time Frame for GBS Screening
Withdrawn
- GBS
- Group B Streptococcal Infection
- genital and rectal swab
- (no location specified)
Dec 26, 2021
Group B Strep Infection Trial in Albuquerque (Probiotic dietary supplement)
Active, not recruiting
- Group B Strep Infection
- Probiotic dietary supplement
-
Albuquerque, New MexicoUniversity of New Mexico Hospital
Jan 19, 2023
MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A
Withdrawn
- Group B Streptococcal Infection
- culture and PCR for group B streptococcus
-
Fayoum, Egyptsahar M.Y elbaradie
Mar 17, 2022
PANDAS, Anxiety Disorder, Autoimmune Diseases Trial in Boston (Naproxen Sodium, Placebo)
Recruiting
- PANDAS
- +3 more
- Naproxen Sodium
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Feb 14, 2022
Colonization With Group B Streptococcus During Pregnancy
Completed
- Gestational Mother
- Streptococcus Agalactiae Infection
-
Madrid, SpainHospital Universitario La Paz
Mar 2, 2022
Group B Streptococcal Infection Trial in Johannesburg, Kawempe (GBS-NN/NN2, Placebo)
Active, not recruiting
- Group B Streptococcal Infection
- GBS-NN/NN2
- Placebo
-
Johannesburg, South Africa
- +2 more
Aug 29, 2022
Pneumococcal Infections, Streptococcal Infections, Bacterial Infections Trial in Anyang (13-Valent Pneumococcal Polysaccharide
Active, not recruiting
- Pneumococcal Infections
- +2 more
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(CRM197,TT)
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
-
Anyang, Henan, ChinaNeihuang Center for Disease Control and Prevention
Aug 2, 2021
Staphylococcal Infection, Streptococcal Infection Trial in Bron (PRIVIGEN (CSL Behring), Albumin)
Withdrawn
- Staphylococcal Infection
- Streptococcal Infection
- PRIVIGEN (CSL Behring)
- Albumin
-
Bron, FranceHôpital Femme Mère Enfant
Apr 28, 2021
Group B Streptococcus Infection Trial in Merthyr Tydfil (GBS-NN/NN2)
Completed
- Group B Streptococcus Infection
- GBS-NN/NN2
-
Merthyr Tydfil, Wales, United KingdomSimbec Clinical Pharmacology
Aug 24, 2022
Group B Streptococcal Infections Trial in Stockbridge, Bardstown, Salt Lake City (Group B streptoccous 6-valent polysaccharide
Completed
- Group B Streptococcal Infections
- Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)
-
Stockbridge, Georgia
- +3 more
Oct 11, 2021
Gestational Mother, Streptococcus Agalactiae Infection Trial in Madrid (Lactobacillus salivarius V4II-90, Placebo)
Completed
- Gestational Mother
- Streptococcus Agalactiae Infection
- Lactobacillus salivarius V4II-90
- Placebo
-
Madrid, SpainHospital Universitario La Paz
Mar 2, 2022
Group B Streptococcus Infections Trial in United States (Multivalent Group B streptococcus vaccine, Tetanus, diphtheria, and
Not yet recruiting
- Group B Streptococcus Infections
- Hexavalent Group B streptococcus vaccine
- +2 more
- (no location specified)
Jan 6, 2022
Serosurveillance Study of Maternally Derived Anti-GBS Antibody
Unknown status
- Group B Streptococcus Carrier in Childbirth
- +4 more
-
Kampala, UgandaMUJHU Care Ltd
Mar 17, 2021
Group B Streptococcus Infections Trial in South Africa, United Kingdom, United States (Multivalent Group B streptococcus
Recruiting
- Group B Streptococcus Infections
- Multivalent Group B streptococcus vaccine
- Placebo
-
Johannesburg, Gauteng, South Africa
- +7 more
Mar 9, 2022
Maternal, Neonatal and Infant Outcomes at Kawempe National
Recruiting
- Group B Streptococcus Carrier in Childbirth
- +4 more
-
Kampala, UgandaMUJHU Care Ltd
Jan 27, 2021